AMICUS THERAPEUTICS, INC. 3 SEC Filings

Filed On	Filing
23 Aug 2023	Form 3: Harford Simon N.r., Chief Financial Officer Holds 0 shares of No securities are beneficially owned
14 Jul 2023	Form 3: Prout Samantha, Chief Accounting Officer Holds 137,003 shares of Common Stock
30 Dec 2022	Form 3: Castelli Jeff, Chief Development Officer Holds 304,255 shares of Common Stock
14 Jun 2021	Form 3: Roberts Eiry, Director No securities owned
02 Dec 2020	Form 3: Kelly Michael Aaron, Director Holds 0 shares of No securities are beneficially owned
17 May 2019	Form 3: Whitman Burke W, Director Holds 0 shares of No Securities Beneficially Owned
11 Oct 2018	Form 3: Clark David Michael, Chief People Officer Holds 1,758 shares of Common Stock
11 Sep 2018	Form 3: Bleil Lynn Dorsey, Director Holds 0 shares of Common Stock
15 Jun 2018	Form 3: Prout Samantha Whiteman, Principal Accounting Officer Holds 5,723 shares of Common Stock
02 Dec 2016	Form 3: Perceptive Advisors Llc, 10% owner and 2 others Holds 13,223,947 shares of Common Stock
16 Jun 2016	Form 3: Wheeler Craig A, Director No securities owned
13 Jun 2016	Form 3: Redmile Group, Llc, 10% owner and 1 other Holds 12,890,146 shares of Common Stock, Par Value $0.01
10 Feb 2016	Form 3: Rosenberg Ellen, General Counsel & Corp. Secy No securities owned
03 Feb 2016	Form 3: Andrews Kurt J., SVP, Human Resources No securities owned
04 Jun 2015	Form 3: Baldry Mark, VP Global Marketing No securities owned
28 Apr 2015	Form 3: David Allsop, SVP International No securities owned
08 Jul 2014	Form 3: Doshi Dipal, SVP Business Planning & Dev No securities owned
30 May 2014	Form 3: Perceptive Advisors Llc, 10% owner and 2 others Holds 8,339,444 shares of Common Stock
10 Mar 2014	Form 3: Barth Jay, Chief Medical Officer No securities owned
03 Dec 2013	Form 3: Yu Julie, Vice President Clinical Ops

Comments